A Health Canada safety review examines the potential risk of hepatotoxicity with oral ashwagandha products following international concerns about a possible association.
A study from Swedish researchers has found that reversing nivolumab and ipilimumab dose amounts improved survival rates, while reducing treatment-related toxicity.
‘This approach would represent a paradigm shift by transforming a common, dose-limiting toxicity into a preventable complication through routine nutritional optimization.’
The move aligns with the advice of many online influencers and podcasters, including men’s health gurus who tout the hormone as a way to boost muscle and energy.
